Skip to main content
. 2011 Sep 23;9(9):1664–1681. doi: 10.3390/md9091664

Figure 5.

Figure 5

Effect of the DRS HE800 derivative on vascular tube formation on Matrigel from endothelial progenitor cells (EPCs). Photographs show vascular tube formation by EPCs previously treated (a) with 5% of fetal calf serum (control); (b) with proangiogenic factor VEGF (40 ng/mL); and (c) with proangiogenic factor VEGF (40 ng/mL) and DRS HE800 derivative (10 μg/mL).